메뉴 건너뛰기




Volumn 15, Issue 5, 2010, Pages 552-557

The contribution of airway and lung tissue ischemia to primary graft dysfunction

Author keywords

biomarker; ischemia reperfusion injury; lung transplantation; primary graft dysfunction

Indexed keywords

GAMMA INTERFERON; HUMAN MONOCLONAL ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN C; RECOMBINANT TISSUE FACTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

EID: 77957558294     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32833e1415     Document Type: Review
Times cited : (21)

References (58)
  • 1
    • 70349231224 scopus 로고    scopus 로고
    • The Registry of the International society for heart and lung transplantation: Twenty-sixth official adult lung and heart-lung transplantation report-2009
    • Christie JD, Edwards LB, Aurora P, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-Sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 2009; 28: 1031-1049.
    • (2009) J Heart Lung Transplant , vol.28 , pp. 1031-1049
    • Christie, J.D.1    Edwards, L.B.2    Aurora, P.3
  • 2
    • 70349237286 scopus 로고    scopus 로고
    • Registry of the international society for heart and lung transplantation: Twenty-sixth official adult heart transplant report-2009
    • Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant 2009; 28: 1007-1022.
    • (2009) J Heart Lung Transplant , vol.28 , pp. 1007-1022
    • Taylor, D.O.1    Stehlik, J.2    Edwards, L.B.3
  • 3
    • 70450230745 scopus 로고    scopus 로고
    • A disease-based comparison of liver transplantation outcomes
    • Mailey B, Buchberg B, Prendergast C., et al. A disease-based comparison of liver transplantation outcomes. Am Surg 2009; 75: 901-908.
    • (2009) Am Surg , vol.75 , pp. 901-908
    • Mailey, B.1    Buchberg, B.2    Prendergast, C.3
  • 4
    • 47049127233 scopus 로고    scopus 로고
    • Immunological link between primary graft dysfunction and chronic lung allograft rejection
    • discussion 196-187
    • Bharat A, Kuo E, Steward N., et al. Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg 2008; 86: 189-195; discussion 196-187.
    • (2008) Ann Thorac Surg , vol.86 , pp. 189-195
    • Bharat, A.1    Kuo, E.2    Steward, N.3
  • 5
    • 33846638258 scopus 로고    scopus 로고
    • Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection
    • Bharat A, Narayanan K, Street T., et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007; 83: 150-158.
    • (2007) Transplantation , vol.83 , pp. 150-158
    • Bharat, A.1    Narayanan, K.2    Street, T.3
  • 6
    • 0031843513 scopus 로고    scopus 로고
    • Primary graft failure following lung transplantation
    • Christie JD, Bavaria JE, Palevsky H.I., et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51-60.
    • (1998) Chest , vol.114 , pp. 51-60
    • Christie, J.D.1    Bavaria, J.E.2    Palevsky, H.I.3
  • 7
    • 19644372963 scopus 로고    scopus 로고
    • The effect of primary graft dysfunction on survival after lung transplantation
    • Christie JD, Kotloff RM, Ahya V.N., et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312-1316.
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 1312-1316
    • Christie, J.D.1    Kotloff, R.M.2    Ahya, V.N.3
  • 8
    • 0142010556 scopus 로고    scopus 로고
    • Clinical risk factors for primary graft failure following lung transplantation
    • Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232-1241.
    • (2003) Chest , vol.124 , pp. 1232-1241
    • Christie, J.D.1    Kotloff, R.M.2    Pochettino, A.3
  • 9
    • 13844306735 scopus 로고    scopus 로고
    • Impact of primary graft failure on outcomes following lung transplantation
    • Christie JD, Sager JS, Kimmel S.E., et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005; 127: 161-165.
    • (2005) Chest , vol.127 , pp. 161-165
    • Christie, J.D.1    Sager, J.S.2    Kimmel, S.E.3
  • 10
    • 25844460135 scopus 로고    scopus 로고
    • Report of the ISHLT working group on primary lung graft dysfunction Part I: Introduction and methods
    • Christie JD, Van Raemdonck D, de Perrot M, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. J Heart Lung Transplant 2005; 24: 1451-1453.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1451-1453
    • Christie, J.D.1    Van Raemdonck, D.2    De Perrot, M.3
  • 11
    • 33847665250 scopus 로고    scopus 로고
    • Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome
    • Daud SA, Yusen RD, Meyers B.F., et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007; 175: 507-513.
    • (2007) Am J Respir Crit Care Med , vol.175 , pp. 507-513
    • Daud, S.A.1    Yusen, R.D.2    Meyers, B.F.3
  • 12
    • 0033922644 scopus 로고    scopus 로고
    • Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation
    • King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681-1685.
    • (2000) Ann Thorac Surg , vol.69 , pp. 1681-1685
    • King, R.C.1    Binns, O.A.2    Rodriguez, F.3
  • 13
    • 25844472471 scopus 로고    scopus 로고
    • Report of the ISHLT working group on primary lung graft dysfunction Part II: Definition. A consensus statement of the international society for heart and lung transplantation
    • Christie JD, Carby M, Bag R., et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454-1459.
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1454-1459
    • Christie, J.D.1    Carby, M.2    Bag, R.3
  • 15
    • 40949137002 scopus 로고    scopus 로고
    • Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation
    • Bobadilla JL, Love RB, Jankowska-Gan E, et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008; 177: 660-668.
    • (2008) Am J Respir Crit Care Med , vol.177 , pp. 660-668
    • Bobadilla, J.L.1    Love, R.B.2    Jankowska-Gan, E.3
  • 16
    • 77949825659 scopus 로고    scopus 로고
    • Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation
    • Pelaez A, Force SD, Gal A.A., et al. Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation. Am J Transplant 2010; 10: 900-907.
    • (2010) Am J Transplant , vol.10 , pp. 900-907
    • Pelaez, A.1    Force, S.D.2    Gal, A.A.3
  • 17
    • 72849136789 scopus 로고    scopus 로고
    • Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction
    • Christie JD, Shah CV, Kawut S.M., et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009; 180: 1010-1015.
    • (2009) Am J Respir Crit Care Med , vol.180 , pp. 1010-1015
    • Christie, J.D.1    Shah, C.V.2    Kawut, S.M.3
  • 18
    • 54049095180 scopus 로고    scopus 로고
    • Antitype V collagen humoral immunity in lung transplant primary graft dysfunction
    • Iwata T, Philipovskiy A, Fisher AJ, et al. Antitype V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008; 181: 5738-5747.
    • (2008) J Immunol , vol.181 , pp. 5738-5747
    • Iwata, T.1    Philipovskiy, A.2    Fisher, A.J.3
  • 19
    • 0034051869 scopus 로고    scopus 로고
    • Cell death in human lung transplantation: Apoptosis induction in human lungs during ischemia and after transplantation
    • Fischer S, Cassivi SD, Xavier A.M., et al. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 2000; 231: 424-431.
    • (2000) Ann Surg , vol.231 , pp. 424-431
    • Fischer, S.1    Cassivi, S.D.2    Xavier, A.M.3
  • 20
    • 33846264111 scopus 로고    scopus 로고
    • Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction
    • Christie JD, Robinson N, Ware L.B., et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007; 175: 69-74.
    • (2007) Am J Respir Crit Care Med , vol.175 , pp. 69-74
    • Christie, J.D.1    Robinson, N.2    Ware, L.B.3
  • 21
    • 35248845510 scopus 로고    scopus 로고
    • Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation
    • Covarrubias M, Ware LB, Kawut S.M., et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573-2578.
    • (2007) Am J Transplant , vol.7 , pp. 2573-2578
    • Covarrubias, M.1    Ware, L.B.2    Kawut, S.M.3
  • 22
    • 33847735943 scopus 로고    scopus 로고
    • Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction
    • Krenn K, Klepetko W, Taghavi S., et al. Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 2007; 7: 700-706.
    • (2007) Am J Transplant , vol.7 , pp. 700-706
    • Krenn, K.1    Klepetko, W.2    Taghavi, S.3
  • 23
    • 76949085987 scopus 로고    scopus 로고
    • Concomitant endothelin-1 over- expression in lung transplant donors and recipients predicts primary graft dysfunction
    • Salama M, Andrukhova O, Hoda M.A., et al. Concomitant endothelin-1 over- expression in lung transplant donors and recipients predicts primary graft dysfunction. Am J Transplant 2010; 10: 628-636.
    • (2010) Am J Transplant , vol.10 , pp. 628-636
    • Salama, M.1    Andrukhova, O.2    Hoda, M.A.3
  • 24
    • 0037096659 scopus 로고    scopus 로고
    • VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts
    • Abraham D, Taghavi S, Riml P., et al. VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation 2002; 73: 1703-1706.
    • (2002) Transplantation , vol.73 , pp. 1703-1706
    • Abraham, D.1    Taghavi, S.2    Riml, P.3
  • 25
    • 34548677516 scopus 로고    scopus 로고
    • Determination of interleukin-6 in lung transplantation: Association with primary graft dysfunction
    • Moreno I, Vicente R, Ramos F., et al. Determination of interleukin-6 in lung transplantation: association with primary graft dysfunction. Transplant Proc 2007; 39: 2425-2426.
    • (2007) Transplant Proc , vol.39 , pp. 2425-2426
    • Moreno, I.1    Vicente, R.2    Ramos, F.3
  • 26
    • 13844256118 scopus 로고    scopus 로고
    • Pulmonary ischaemia-reperfusion injury: Role of apoptosis
    • Ng CS, Wan S, Yim AP Pulmonary ischaemia-reperfusion injury: role of apoptosis. Eur Respir J 2005; 25: 356-363.
    • (2005) Eur Respir J , vol.25 , pp. 356-363
    • Ng, C.S.1    Wan, S.2    Yim, A.P.3
  • 27
    • 0033678845 scopus 로고    scopus 로고
    • Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation
    • Fischer S, Maclean AA, Liu M, et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 2000; 162: 1932-1939.
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 1932-1939
    • Fischer, S.1    Maclean, A.A.2    Liu, M.3
  • 28
    • 33646243227 scopus 로고    scopus 로고
    • Receptor for advanced glycation endproducts is a marker of type I cell injury in acute lung injury
    • Uchida T, Shirasawa M, Ware L.B., et al. Receptor for advanced glycation endproducts is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006; 173: 1008-1015.
    • (2006) Am J Respir Crit Care Med , vol.173 , pp. 1008-1015
    • Uchida, T.1    Shirasawa, M.2    Ware, L.B.3
  • 29
    • 67650069965 scopus 로고    scopus 로고
    • Receptor for advanced glycation end-products RAGE; is an indicator of direct lung injury in models of experimental lung injury
    • Su X, Looney MR, Gupta N, Matthay MA Receptor for advanced glycation end-products RAGE; is an indicator of direct lung injury in models of experimental lung injury. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1-5.
    • (2009) Am J Physiol Lung Cell Mol Physiol , vol.297
    • Su, X.1    Looney, M.R.2    Gupta, N.3    Matthay, M.A.4
  • 30
    • 57149101367 scopus 로고    scopus 로고
    • Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury
    • Calfee CS, Ware LB, Eisner M.D., et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63: 1083-1089.
    • (2008) Thorax , vol.63 , pp. 1083-1089
    • Calfee, C.S.1    Ware, L.B.2    Eisner, M.D.3
  • 31
    • 60249099585 scopus 로고    scopus 로고
    • Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs
    • Briot R, Frank JA, Uchida T, et al. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009; 135: 269-275.
    • (2009) Chest , vol.135 , pp. 269-275
    • Briot, R.1    Frank, J.A.2    Uchida, T.3
  • 32
    • 33644762252 scopus 로고    scopus 로고
    • Antitype V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well healed lung transplants
    • Yoshida S, Haque A, Mizobuchi T., et al. Antitype V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well healed lung transplants. Am J Transplant 2006; 6: 724-735.
    • (2006) Am J Transplant , vol.6 , pp. 724-735
    • Yoshida, S.1    Haque, A.2    Mizobuchi, T.3
  • 33
    • 0036681923 scopus 로고    scopus 로고
    • Evidence for immune responses to a self-antigen in lung transplantation: Role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection
    • Haque MA, Mizobuchi T, Yasufuku K., et al. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002; 169: 1542-1549.
    • (2002) J Immunol , vol.169 , pp. 1542-1549
    • Haque, M.A.1    Mizobuchi, T.2    Yasufuku, K.3
  • 34
    • 67650809255 scopus 로고    scopus 로고
    • Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation
    • Kawut SM, Okun J, Shimbo D., et al. Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Chest 2009; 136: 237-244.
    • (2009) Chest , vol.136 , pp. 237-244
    • Kawut, S.M.1    Okun, J.2    Shimbo, D.3
  • 35
    • 36048968753 scopus 로고    scopus 로고
    • IL-1 7-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants
    • Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-1 7-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 3498-3506.
    • (2007) J Clin Invest , vol.117 , pp. 3498-3506
    • Burlingham, W.J.1    Love, R.B.2    Jankowska-Gan, E.3
  • 36
    • 0028519737 scopus 로고
    • In situ ischemia and hypoxia enhance alveolar macrophage tissue factor expression
    • Compeau CG, Ma J, DeCampos K.N., et al. In situ ischemia and hypoxia enhance alveolar macrophage tissue factor expression. Am J Respir Cell Mol Biol 1994; 11: 446-455.
    • (1994) Am J Respir Cell Mol Biol , vol.11 , pp. 446-455
    • Compeau, C.G.1    Ma, J.2    DeCampos, K.N.3
  • 37
    • 0032167429 scopus 로고    scopus 로고
    • Coordinated induction of plasminogen activator inhibitor-1 PAI-1; and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition
    • Pinsky DJ, Liao H, Lawson C.A., et al. Coordinated induction of plasminogen activator inhibitor-1 PAI-1; and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 1998; 102: 919-928.
    • (1998) J Clin Invest , vol.102 , pp. 919-928
    • Pinsky, D.J.1    Liao, H.2    Lawson, C.A.3
  • 39
    • 77951208211 scopus 로고    scopus 로고
    • PTX3 as a potential biomarker of acute lung injury: Supporting evidence from animal experimentation
    • He X, Han B, Bai X., et al. PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med 2010; 36: 356-364.
    • (2010) Intensive Care Med , vol.36 , pp. 356-364
    • He, X.1    Han, B.2    Bai, X.3
  • 40
    • 0036242881 scopus 로고    scopus 로고
    • Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion
    • Taghavi S, Abraham D, Riml P., et al. Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant 2002; 21: 600-603.
    • (2002) J Heart Lung Transplant , vol.21 , pp. 600-603
    • Taghavi, S.1    Abraham, D.2    Riml, P.3
  • 41
    • 4644286455 scopus 로고    scopus 로고
    • Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury
    • Ware LB, Eisner MD, Thompson B.T., et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004; 170: 766-772.
    • (2004) Am J Respir Crit Care Med , vol.170 , pp. 766-772
    • Ware, L.B.1    Eisner, M.D.2    Thompson, B.T.3
  • 42
    • 0035671508 scopus 로고    scopus 로고
    • Von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury
    • Ware LB, Conner ER, Matthay MA von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001; 29: 2325-2331.
    • (2001) Crit Care Med , vol.29 , pp. 2325-2331
    • Ware, L.B.1    Conner, E.R.2    Matthay, M.A.3
  • 43
    • 0025128163 scopus 로고
    • Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome
    • Rubin DB, Wiener-Kronish JP, Murray J.F., et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86: 474-480.
    • (1990) J Clin Invest , vol.86 , pp. 474-480
    • Rubin, D.B.1    Wiener-Kronish, J.P.2    Murray, J.F.3
  • 44
    • 0028607386 scopus 로고
    • The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft
    • Serrick C, Adoumie R, Giaid A., Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994; 58: 1158-1162.
    • (1994) Transplantation , vol.58 , pp. 1158-1162
    • Serrick, C.1    Adoumie, R.2    Giaid, A.3    Shennib, H.4
  • 45
    • 0343894289 scopus 로고
    • Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells
    • Oz MC, Liao H, Naka Y., et al. Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. Circulation 1995; 92 (9 SUPPL.): II428-432.
    • (1995) Circulation , vol.92 , Issue.9 SUPPL.
    • Oz, M.C.1    Liao, H.2    Naka, Y.3
  • 46
    • 0034653592 scopus 로고    scopus 로고
    • Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury
    • Lemay S, Rabb H, Postler G., Singh AK Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 2000; 69: 959-963.
    • (2000) Transplantation , vol.69 , pp. 959-963
    • Lemay, S.1    Rabb, H.2    Postler, G.3    Singh, A.K.4
  • 47
    • 0344563613 scopus 로고    scopus 로고
    • Local liberation of cytokines during liver preservation
    • Gerlach J, Jorres A, Nohr R., et al. Local liberation of cytokines during liver preservation. Transpl Int 1999; 12: 261-265.
    • (1999) Transpl Int , vol.12 , pp. 261-265
    • Gerlach, J.1    Jorres, A.2    Nohr, R.3
  • 48
    • 37849034995 scopus 로고    scopus 로고
    • Interleukin-8 expression in lung tissue during ischemia-reperfusion
    • Matilla JM, Garcia Yuste M, Sanchez Crespo M, et al. Interleukin-8 expression in lung tissue during ischemia-reperfusion. Arch Bronconeumol 2007; 43: 542-548.
    • (2007) Arch Bronconeumol , vol.43 , pp. 542-548
    • Matilla, J.M.1    Garcia Yuste, M.2    Sanchez Crespo, M.3
  • 49
    • 0037080909 scopus 로고    scopus 로고
    • Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation
    • De Perrot M., Sekine Y, Fischer S., et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002; 165: 211-215.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 211-215
    • De Perrot, M.1    Sekine, Y.2    Fischer, S.3
  • 50
    • 58849086671 scopus 로고    scopus 로고
    • Plasma cytokines and chemokines in primary graft dysfunction postlung transplantation
    • Hoffman SA, Wang L, Shah C.V., et al. Plasma cytokines and chemokines in primary graft dysfunction postlung transplantation. Am J Transplant 2009; 9: 389-396.
    • (2009) Am J Transplant , vol.9 , pp. 389-396
    • Hoffman, S.A.1    Wang, L.2    Shah, C.V.3
  • 51
    • 57649237744 scopus 로고    scopus 로고
    • Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo
    • Ingemansson R, Eyjolfsson A, Mared L., et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009; 87: 255-260.
    • (2009) Ann Thorac Surg , vol.87 , pp. 255-260
    • Ingemansson, R.1    Eyjolfsson, A.2    Mared, L.3
  • 52
    • 57149102713 scopus 로고    scopus 로고
    • Technique for prolonged normothermic ex vivo lung perfusion
    • Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27: 1319-1325.
    • (2008) J Heart Lung Transplant , vol.27 , pp. 1319-1325
    • Cypel, M.1    Yeung, J.C.2    Hirayama, S.3
  • 53
    • 70349218771 scopus 로고    scopus 로고
    • Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation
    • Cypel M, Rubacha M, Yeung J., et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9: 2262-2269.
    • (2009) Am J Transplant , vol.9 , pp. 2262-2269
    • Cypel, M.1    Rubacha, M.2    Yeung, J.3
  • 54
    • 77952001279 scopus 로고    scopus 로고
    • Functional repair of human donor lungs by IL-10 gene therapy
    • Cypel M, Liu M, Rubacha M., et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009; 1: 4ra9.
    • (2009) Sci Transl Med , vol.1
    • Cypel, M.1    Liu, M.2    Rubacha, M.3
  • 55
    • 66249105705 scopus 로고    scopus 로고
    • Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques: Non-heart-beating donor lung retrieval and ex vivo donor lung perfusion
    • Yeung JC, Cypel M, Waddell T.K., et al. Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques: non-heart-beating donor lung retrieval and ex vivo donor lung perfusion. Thorac Surg Clin 2009; 19: 261-274.
    • (2009) Thorac Surg Clin , vol.19 , pp. 261-274
    • Yeung, J.C.1    Cypel, M.2    Waddell, T.K.3
  • 56
    • 60849114993 scopus 로고    scopus 로고
    • Ugarte: Present state of nonheart-beating lung donation
    • de Antonio D.G., de AV Ugarte: present state of nonheart-beating lung donation. Curr Opin Organ Transplant 2008; 13: 659-663.
    • (2008) Curr Opin Organ Transplant , vol.13 , pp. 659-663
    • De Antonio, D.G.1    De, A.V.2
  • 58
    • 0346374590 scopus 로고    scopus 로고
    • Nonheart-beating donors in thoracic transplantation
    • Egan TM. Nonheart-beating donors in thoracic transplantation. J Heart Lung Transplant 2004; 23: 3-10.
    • (2004) J Heart Lung Transplant , vol.23 , pp. 3-10
    • Egan, T.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.